Copyright
©The Author(s) 2021.
World J Gastrointest Pathophysiol. Sep 22, 2021; 12(5): 84-105
Published online Sep 22, 2021. doi: 10.4291/wjgp.v12.i5.84
Published online Sep 22, 2021. doi: 10.4291/wjgp.v12.i5.84
Gene (location) | Function | Epigenetic modification/effect | Outcome | Ref. |
p16INK4A or CDKN2A (9p21) | Tumor suppressor gene Regulates cell proliferation and oncogenesis | Promoter region hypermethylation of the p16INK4A results in gene inactivation. Common event in PSC-associated CCA | More frequent in ECC cases. More commonly observed in tumors with vascular invasion. Poor clinical outcome | Ueki et al[115], 2004 |
p14ARF(9p21) | Encoded by the β transcript of CDKN2A (p16/CDKN2A) | Methylation of p14ARF MF = 38 and 25% (32.35); 40.2% liver fluke CCA (37) | Increased tumorigenesis in CCA | Kim et al[116], 2007 |
p15INK4b or p15 (9p21) | Effecter of TGF-β-mediated cell cycle arrest | Promoter hypermethylation of p15 gene | Increased tumorigenesis in CCA | Yang et al[117], 2005 |
p73 gene (1p36.3) | Tumor suppressor gene and related to the p53 gene | Promoter region hypermethylation increased tumorigenesis | Increased tumorigenesis in CCA | |
TMS1/ASC (16p11.2) | Tumor suppressor gene | Aberrant methylation of the TMS1/ASC cause inactivation of gene | Associated with CCA | Liu et al[118], 2006 |
FHIT (3p14.2) | Tumor suppressor gene | Promoter hypermethylation of the FHIT gene results in epigenetic silencing of the FHIT promoter region | Development of intrahepatic CCAs | Foja et al[119], 2005 |
RASSF1A (3p21.3) | Tumor suppressor gene induces cell cycle arrest by inhibiting the accumulation of cyclin D1 | Hypermethylation of its CpG island promoter region results in inactivation | Promoter methylation is more common in ECC than | Wong et al[120], 2002 |
hMLH1 (3p21.3) | DNA mismatch repair gene | Promoter methylation/hypermethylation of the hMLH1 gene | Methylation frequencies vary in sporadic CCA, biliary papillary, neoplasms, and liver fluke-related CCA. Associated with poorly differentiated subtype of CCA with vascular invasion | Yang et al[117], 2005 |
APC (5q21–q22) | Tumor suppressor gene Controls cell division, cell-cell interactions and cell migration and invasion, and conservation of chromosomal number during cell division | APC gene hypermethylation | Worse clinical outcome in CCA | Yang et al[117], 2005 |
RAR-β (or HAP, RRB2 and NR1B2) (3p24) | Mediates cellular signaling in embryonic morphogenesis, cell growth and differentiation by regulating gene expression | Gene silencing by promoter region hypermethylation Results in increased tumorigenesis | Increased tumorigenesis in CCA | |
Epithelial (E) cadherin gene (16q22.1) | Tumor suppressor gene | Hypermethylation of the promoter region of E gene Results in loss of function and contribute to progression of cancer by increasing proliferation, invasion and metastasis | Development of intrahepatic CCA | Lee et al[121], 2002 |
DAPK (9q34.1) | Tumor suppressor gene Positive mediator of interferon-γ (IFN-γ)-induced programmed cell death | DAPK gene hypermethylation | Associated with poorly differentiated CCAs and with a poor prognosis | Tozawa et al[122], 2004 |
CHFR gene (12q24.33) | Tumor suppressor gene Delays the entry into the metaphase | Gene silencing by promoter hypermethylation | Increased tumorigenesis in CCA | |
RUNX3 gene (Ip36) | Tumor suppressor gene Regulate proliferation of the biliary tract epithelium | Methylation of RUNX3 results in gene silencing | Associated with poorer survival | |
GSTP gene (1q43) | Regulate drug and xenobiotic. metabolism | Promoter region hypermethylation | Hypermethylation more frequent in ICCA than in ECC | Lee et al[121], 2002 |
MGMT gene (10q26) | Responsible for repairing alkylation. DNA damage inhibits estrogen receptor-mediated cell proliferation | Methylation of discrete regions of the MGMT CpG island, results in heterochromatinization of the MGMT transcription start site and silencing of the gene | Increased frequency of GC to AT transitions in oncogenes and tumor suppressor genes and a poor prognosis | Koga et al[123], 2005 |
BLU gene (3p21.3) | Tumor suppressor gene | Gene methylation | Increased tumorigenesis in CCA | Tischoff et al[124], 2005 |
SEMA3B (3p21.3) | Tumor suppressor gene by inducing apoptosis. Plays a critical role in the guidance of growth cones during neuronal development | Methylation of SEMA3B gene | Increased tumorigenesis in CCA | |
TIMP3 gene (22q12.3) | Plays a role in the induction of apoptosis | CpG island methylation of TIMP3 gene | Associated with worse survival | Lee et al[121], 2002 |
RIZ1 | Tumor suppressor gene | Methylation of RIZ1 Results in chromatin compaction and gene silencing MF = 38% liver fluke CCA (47) | Increased proliferation and migration of CCA cell line | Khaenam et al[125], 2010 |
OPCML | Tumor suppressor gene | Hypermethylation of OPCML | Increased tumorigenesis in CCA | Sriraksa et al[126], 2011 |
GSTP1 | Tumor suppressor gene | Methylation of GSTP1 | Increased tumorigenesis in CCA | Yang et al[117], 2005 |
COX-2/PTGS2 (1q25.2–q25.3) | Acts both as a dioxygenase and as a peroxidase | Methylation of COX-2 gene | Increased tumorigenesis in CCA | Lee et al[121], 2002 |
THBS1 gene (15q15) | Mediates cell-to-cell and cell-to-matrix interactions and play roles in platelet aggregation, angiogenesis and tumorigenesis | Hypermethylation in the promoter region of THBS1 gene | Increased tumorigenesis in CCA | Tischoff et al[124], 2005 |
SOCS3 | responsible for sustained IL-6/STAT-3 signaling and enhanced Mcl-1 expression in cholangiocarcinoma | Hypermethylation in the promoter region of SOCS3 gene | Increased tumorigenesis in CCA | Zhang et al[127], 2012 |
- Citation: Safarpour AR, Askari H, Ejtehadi F, Azarnezhad A, Raeis-Abdollahi E, Tajbakhsh A, Abazari MF, Tarkesh F, Shamsaeefar A, Niknam R, Sivandzadeh GR, Lankarani KB, Ejtehadi F. Cholangiocarcinoma and liver transplantation: What we know so far? World J Gastrointest Pathophysiol 2021; 12(5): 84-105
- URL: https://www.wjgnet.com/2150-5330/full/v12/i5/84.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v12.i5.84